Skip to main content
Premium Trial:

Request an Annual Quote

Nonlinear Dynamics Says It Won t Renew 2D Gel Software OEM Deal with Amersham

NEW YORK, July 18 - Nonlinear Dynamics announced today that it has decided not to renew its OEM agreement to supply Amersham Biosciences' proteomics group with 2D gel analysis software.

 

This means that Amersham will no longer use Nonlinear Dynamics software in its ImageMaster 2D, ImageMaster 2D Evolution, Ettan Progenesis Workstation or Ettan Progenesis Discovery products.

 

The company has had this OEM agreement with Amersham since 1996.

 

"However we feel that Nonlinear and Amersham Biosciences' priorities within proteomics have diverged over the past two years," said Will Dracup, Nonlinear Dynamics' CEO, in a statement. "We therefore felt it was no longer in our best interests to be represented by them within this market."

 

This disclosure follows Wednesday's announcement by Amersham and GeneBio that Amersham would integrate GeneBio's Melanie 2-D gel analysis software into the ImageMaster image analysis application

 

For the full story on this change, see BioInform.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.